Pfizer in talks with 90 countries for its anti-Covid pill: CEO

Expects to price its treatment close to where Merck has priced its oral antiviral drug candidate.



By Reuters

Published: Fri 5 Nov 2021, 11:32 PM

Pfizer Inc is in discussions with 90 countries over supply contracts for its experimental Covid-19 pill, which was shown to reduce by 89 per cent the risk of hospitalisation or death in patients at high risk of severe illness, Chief Executive Officer Albert Bourla said in an interview on Friday.

He said Pfizer expects to price its treatment, called Paxlovid, close to where rival Merck & Co Inc has priced its oral antiviral drug candidate.

Merck's US contract price for its pill molnupiriavr is around $700 for a five-day course of therapy.


More news from coronavirus